Paul Loren Swiecicki, MD
Specialty:
Medical Oncology, Internal Medicine
Title: Clinical Associate Professor
To request an appointment call
Paul Loren Swiecicki, MD
Medical Oncology
Manage Your Profile
Areas of Practice
head and neck cancer, salivary gland cancer, adenoid cystic carcinoma, phase 1 clinical trials, oropharyngeal cancer, laryngeal cancer, oral cavity cancer, cutaneous squamous cell carcinoma
Locations
-
Head and Neck Oncology Clinic | Rogel Cancer Center 1500 E Medical Center Dr
Floor B1 Reception E
Ann Arbor, MI 48109-5912Get Directions -
Otolaryngology Clinic | Taubman Center 1500 E Medical Center Dr
Floor 1 Reception A
Ann Arbor, MI 48109-5312Get Directions
Insurance Accepted
University of Michigan Health participates with most health insurance plans.
Education & Training
Medical School or Training
Michigan State University-College of Human Medicine, 2011
Residency
Mayo Clinic, Internal Medicine, 2014
Fellowships
University of Michigan Health System, Internal Medicine Hematology Oncology, 2017
Board Certifications
Medical Oncology
Professional Organizations
American College of Physicians
American Medical Association
American Society of Clinical Oncology
American Society of Hematology
Research Overview
My research focuses on development of novel therapeutics for advanced head and neck cancer, advancing new biomarkers which could help guide patient care/management, identifying treatments for metastatic salivary gland cancers, and conducting early phase clinical trials.
Featured News & Stories
Health Lab
Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers
University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.
